This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lopez, J. I. Articles by Schroeder, J. A. Search for Related Content PubMed PubMed Citation Articles by Lopez, J. I. Articles by Schroeder, J. A.

CD44 Attenuates Metastatic Invasion during Breast Cancer Progression

¹ Department of Molecular and Cellular Biology and Arizona Cancer Center; ² Department of Pharmacology and Toxicology and Steele Children's Research Center; ³ Bio5 Institute, University of Arizona, Tucson, Arizona; and ⁴ Mayo Clinic Scottsdale, Scottsdale, Arizona

Requests for reprints: Joyce A. Schroeder, Arizona Cancer Center, 1515 North Campbell Avenue, Tucson, AZ 85724. Phone: 520-626-1384; Fax: 520-626-3764; E-mail: jschroeder{at}azcc.arizona.edu.

Metastatic invasion is the primary cause of breast cancer mortality, and adhesion receptors, such as CD44, are believed to be critical in this process. Historically, primary breast tumor epithelium has been investigated in isolation from other tissue components, leading to the common interpretation that CD44 and its primary ligand, hyaluronan, promote invasion. Here, we provide in vivo evidence showing CD44 antagonism to breast cancer metastasis. In a mouse model of spontaneously metastasizing breast cancer (MMTV-PyV mT), we found that loss of CD44 promotes metastasis to the lung. Localization studies, in combination with a novel hyaluronan synthase-GFP transgenic mouse, show a restricted pattern of expression for CD44 and hyaluronan. Whereas CD44 is expressed in tumor epithelium, hyaluronan synthase expression is restricted to stromal-associated cells. This distinct CD44 and hyaluronan pattern of distribution suggests a role for epithelial-stromal interaction in CD44 function. To define the relevance of this spatial regulation, we developed an in vitro invasion assay to emulate invasion into the extracellular matrix. Invasion of CD44-positive tumor cells was inhibited in hyaluronan-containing matrices, whereas blocking CD44-hyaluronan association increased invasion. Collectively, these data show that during breast cancer progression, hyaluronan-CD44 dynamics occurring through epithelial-stromal interactions are protective against metastasis.

This article has been cited by other articles:

				E. Izumchenko, M. K. Singh, O. V. Plotnikova, N. Tikhmyanova, J. L. Little, I. G. Serebriiskii, S. Seo, M. Kurokawa, B. L. Egleston, A. Klein-Szanto, et al. NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development Cancer Res., September 15, 2009; 69(18): 7198 - 7206. [Abstract] [Full Text] [PDF]

				S. Misra, L. M. Obeid, Y. A. Hannun, S. Minamisawa, F. G. Berger, R. R. Markwald, B. P. Toole, and S. Ghatak Hyaluronan Constitutively Regulates Activation of COX-2-mediated Cell Survival Activity in Intestinal Epithelial and Colon Carcinoma Cells J. Biol. Chem., May 23, 2008; 283(21): 14335 - 14344. [Abstract] [Full Text] [PDF]

				C. A. Maxwell, J. McCarthy, and E. Turley Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J. Cell Sci., April 1, 2008; 121(7): 925 - 932. [Abstract] [Full Text] [PDF]

				A. Ouhtit, Z. Y. Abd Elmageed, M. E. Abdraboh, T. F. Lioe, and M. H.G. Raj In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver Am. J. Pathol., December 1, 2007; 171(6): 2033 - 2039. [Abstract] [Full Text] [PDF]

				S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells J. Biol. Chem., June 1, 2007; 282(22): 16667 - 16680. [Abstract] [Full Text] [PDF]

				S. Misra, B. P. Toole, and S. Ghatak Hyaluronan Constitutively Regulates Activation of Multiple Receptor Tyrosine Kinases in Epithelial and Carcinoma Cells J. Biol. Chem., November 17, 2006; 281(46): 34936 - 34941. [Abstract] [Full Text] [PDF]

				M. Gotte and G. W. Yip Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective Cancer Res., November 1, 2006; 66(21): 10233 - 10237. [Abstract] [Full Text] [PDF]